Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
JAMA Neurol
; 2020 Aug 24.
Article
in En
| MEDLINE
| ID: mdl-32852530
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
JAMA Neurol
Year:
2020
Type:
Article